sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Neurological Biomarkers Market for Alzheimers and Parkinsons Diseases - Global Opportunity Analysis and Industry Forecast, 2018-2025

Neurological Biomarkers Market for Alzheimers and Parkinsons Diseases - Global...

Home / Categories / Healthcare
Neurological Biomarkers Market for Alzheimers and Parkinsons Diseases - Global Opportunity Analysis and Industry Forecast, 2018-2025
Neurological Biomarkers Market for Alzheimers...
Report Code
RO1/113/1381

Publish Date
01/Jun/2018

Pages
90
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
1.4.4. Key assumptions
1.4.5. Key experts

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Top winning strategies
3.3. Overall Diagnostic Market Size

3.3.1. Total diagnostic market size by diagnostic techniques

3.4. Incidence, Mortality, Diagnosis Rate, Prevalence Rate and Treatment Rate for Alzheimers And Parkinsons Disease

3.4.1. Incidence rate
3.4.2. Mortality
3.4.3. Diagnosis rate
3.4.4. Prevalence rate
3.4.5. Treatment rate

3.5. Porters five forces analysis
3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Increasing focus on developing cost-effective biomarker testing
3.6.1.2. Rising demand for non-invasive diagnostic techniques for Alzheimers and Parkinsons
3.6.1.3. Increase in the adoption of neurological biomarkers in clinical trials

3.6.2. Restraints

3.6.2.1. Stringent government regulations
3.6.2.2. Emerging ethical issues regarding early diagnosis of Alzheimers and Parkinsons

3.6.3. Opportunity

3.6.3.1. Rise in the demand for personalized medicine

CHAPTER 4: ALZHEIMER'S DISEASE BIOMARKERS MARKET, BY REGION

4.1. Overview

4.1.1. Market size and forecast

4.2. U.S.

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast

4.3. EU5

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast

4.4. Rest of Europe

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast

4.5. China

4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast

4.6. Asia-Pacific

4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast

4.7. Rest of World (ROW)

4.7.1. Key market trends and opportunities
4.7.2. Market size and forecast

CHAPTER 5: PARKINSONS DISEASE BIOMARKERS MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. U.S.

5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast

5.3. EU5

5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast

5.4. Rest of Europe

5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast

5.5. China

5.5.1. Key market trends and opportunities
5.5.2. Key market trends and opportunities
5.5.3. Market size and forecast

5.6. Asia-Pacific

5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast

5.7. ROW

5.7.1. Key market trends and opportunities
5.7.2. Market size and forecast

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com